- Home
- PRK vs CPRX Comparison
PRK vs CPRX Comparison
Compare PRK & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRK
- CPRX
- Stock Information
- Founded
- PRK 1908
- CPRX 2002
- Country
- PRK United States
- CPRX United States
- Employees
- PRK N/A
- CPRX N/A
- Industry
- PRK Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- PRK Finance
- CPRX Health Care
- Exchange
- PRK Nasdaq
- CPRX Nasdaq
- Market Cap
- PRK 2.6B
- CPRX 2.9B
- IPO Year
- PRK N/A
- CPRX 2006
- Fundamental
- Price
- PRK $161.08
- CPRX $24.90
- Analyst Decision
- PRK Hold
- CPRX Strong Buy
- Analyst Count
- PRK 1
- CPRX 7
- Target Price
- PRK $170.00
- CPRX $32.29
- AVG Volume (30 Days)
- PRK 54.2K
- CPRX 1.1M
- Earning Date
- PRK 07-21-2025
- CPRX 05-07-2025
- Dividend Yield
- PRK 2.93%
- CPRX N/A
- EPS Growth
- PRK 23.42
- CPRX 178.13
- EPS
- PRK 9.75
- CPRX 1.57
- Revenue
- PRK $515,788,000.00
- CPRX $534,645,999.00
- Revenue This Year
- PRK $7.96
- CPRX $16.37
- Revenue Next Year
- PRK $3.31
- CPRX $8.80
- P/E Ratio
- PRK $16.67
- CPRX $15.85
- Revenue Growth
- PRK 10.66
- CPRX 29.97
- 52 Week Low
- PRK $131.93
- CPRX $14.75
- 52 Week High
- PRK $207.99
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- PRK 49.76
- CPRX 58.78
- Support Level
- PRK $162.28
- CPRX $24.19
- Resistance Level
- PRK $165.67
- CPRX $25.00
- Average True Range (ATR)
- PRK 2.87
- CPRX 0.72
- MACD
- PRK -1.03
- CPRX 0.05
- Stochastic Oscillator
- PRK 14.01
- CPRX 78.41
About PRK Park National Corporation
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).